Ghost Tree Capital’s Bicycle Therapeutics BCYC Stock Holding History

Ghost Tree Capital’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100,000	Closed	-$4.39M	–	36
2022 Q1	$4.39M	Buy	+100,000	New	+$4.67M	0.95%	20
2021 Q4	–	Sell	-100,000	Closed	-$4.16M	–	53
2021 Q3	$4.16M	Sell	100,000 -100,000	-50%	-$3.5M	1.22%	32
2021 Q2	$6.07M	Buy	200,000 +50,000	+33%	+$1.51M	1.67%	23
2021 Q1	$4.48M	Buy	+150,000	New	+$3.87M	1.05%	34

Other funds holding BCYC

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Ghost Tree Capital's BCYC Position: Q2 2022 in Review

Ghost Tree Capital sold out of Bicycle Therapeutics (BCYC) in Q2 2022, closing a stake of 100,000 shares — an estimated $4.39M sold.

Ghost Tree Capital first reported a position in BCYC in Q1 2021 and held it in 4 quarters. The position peaked at $6.07M in Q2 2021. 81 funds tracked by Wall St. Rank hold BCYC as of Q2 2022.

Ghost Tree Capital reported no remaining Bicycle Therapeutics position as of Q2 2022 after selling out during the quarter.
Ghost Tree Capital sold 100,000 Bicycle Therapeutics shares in Q2 2022, an estimated $4.39M.
Ghost Tree Capital first reported a position in Bicycle Therapeutics in Q1 2021 and held it in 4 quarters.
Ghost Tree Capital's Bicycle Therapeutics position peaked at $6.07M in Q2 2021.
81 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2022.

Based on Ghost Tree Capital's 13F filing for Q2 2022, filed 15 Aug 2022.